Fulvestrant
ATOS-2015-007
Phase 2 small_molecule terminated
Quick answer
Fulvestrant for Female Breast Carcinoma is a Phase 2 program (small_molecule) at ATOSSA THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ATOSSA THERAPEUTICS, INC.
- Indication
- Female Breast Carcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated